Skip to main content
Caplight Logo









Bioplastix

Bioplastix

Private
CuernavacaEnergy & Sustainabilityhttps://bio-plastix.com/

Last Round

Seed

Jan 1, 2026

Total Funding Raised

$266,000

Company Overview

Bioplastix is a biotechnology company that develops genome-engineered biopolymer production technology to enable cost-efficient and scalable biodegradable materials.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Biotechnology, Advanced Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologybioplasticsprecision fermentationbiopolymermetabolic engineeringhome-compostable plasticsstrain optimizationsustainable materialsbiotechclean manufacturingindustrial biotechnologybio-manufacturingbioprocess engineeringgreen chemistrytech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioplastix Comparables

Compare Bioplastix with similar companies based on industry and business-model similarity.

Bioplastix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genecis Bioindustries
77%
PhaBuilder
74%
Bioplastech Ltd
66%

Bioplastix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2026
GrantFeb 17, 2025
AcceleratorOct 7, 2024

Key People

Founding team and executive leadership

Gilberto Pérez Morales

Founder Chief Technology Officer

Founding Team

Karina Campos

Chief Executive Officer

Executive Team

Bioplastix Investors

Notable investors and investment history

Bioplastix investors
InvestorRounds
Start-Up ChileGrant
GRIDXAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 20, 2026

    Grew 33% QoQ from 9 to 12 employees.

  • Jun 4, 2025

    Grew 60% QoQ from 5 to 8 employees.

Bioplastix Filings

Explore SEC and related filing metadata, where available.

Bioplastix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bioplastix's valuation, stock price, and market status.

Is Bioplastix a public or private company?

Bioplastix is a private company.

What is the current stock price of Bioplastix?

Bioplastix is a private company with no public stock price. No recent secondary market data is available.

How much is Bioplastix worth (valuation)?

Valuation information for Bioplastix is not publicly available.

Can I buy Bioplastix stock?

Bioplastix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bioplastix's last funding round?

Bioplastix's most recent funding round was Seed on January 1, 2026.

Who are the main investors in Bioplastix?

Key investors in Bioplastix include GRIDX.

Will Bioplastix IPO soon?

No public IPO plans have been announced for Bioplastix.

How can I track Bioplastix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioplastix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCuernavaca
Employee Range9
Year Founded2024
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?